NCT03738722View on ClinicalTrials.gov

Positive Airway Pressure Under Apnoeic Oxygenation With Different Flow Rates in Nasal Cannula Therapy

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Apnoeic Oxygenation
Interventions
DRUG

Oxygen

HFNCT (high flow nasal cannula therapy) will be provided using OptiFlow by Fisher\&Paykel.

Trial Locations (1)

3011

Bern University Hospital and University of Bern, Bern

All Listed Sponsors
collaborator

University of Bern

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT03738722 - Positive Airway Pressure Under Apnoeic Oxygenation With Different Flow Rates in Nasal Cannula Therapy | Biotech Hunter | Biotech Hunter